IHMT-PI3Kδ-372 New
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 2429889-62-1 | Cat. No. | BCP46775 |
| Name | IHMT-PI3Kδ-372 | ||
| Synonyms | |||
| SMILES | CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3CC3)N4C5=NC=NC(=C5C(=N4)C6=CC(=C(C=C6)OC)F)N | ||
| Chemical Name | |||
| Formula | C26H23F2N7O2 | M. Wt | 503.5 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | IHMT-PI3Kδ-372 is a potent and selective PI3Kδ inhibitor with an IC50 of 14 nM. IHMT-PI3Kδ-372 shows high selectivity over other class I PI3Ks (56∼83 fold) and other protein kinases. IHMT-PI3Kδ-372 can be uesd for chronic obstructive pulmonary disease (COPD) research. | ||
Recommend Products
More >
-
-
PI3K/mTOR Inhibitor-2
Cat. No.：BCP48401
No.：1848242-58-9
Product Details -
-
Disitertide
Cat. No.：BCP46789
No.：272105-42-7
Product Details -
Gilmelisib
Cat. No.：BCP46378
No.：1845777-61-8
Product Details -
-
ETP-45658
Cat. No.：BCP45165
No.：1198357-79-7
Product Details -
-
Panulisib
Cat. No.：BCP44105
No.：1356033-60-7
Product Details -
Parsaclisib hydrochloride
Cat. No.：BCP42656
No.：1995889-48-9
Product Details -
-
-
-
Nemiralisib
Cat. No.：BCP38658
No.：1254036-71-9
Product Details -
SAR405 R enantiomer
Cat. No.：BCP37991
No.：1946010-79-2
Product Details -
TGR1202 racemate
Cat. No.：BCP24685
No.：1532533-65-5
Product Details -
Umbralisib tosylate
Cat. No.：BCP24684
No.：1532533-72-4
Product Details -
Umbralisib R-enantiomer
Cat. No.：BCP24683
No.：1532533-69-9
Product Details -
Umbralisib sulfate
Cat. No.：BCP24681
No.：1532533-75-7
Product Details -
GSK2292767
Cat. No.：BCP24323
No.：1254036-66-2
Product Details
Tags:IHMT-PI3Kδ-372 supplier,IHMT-PI3Kδ-372 purchase,IHMT-PI3Kδ-372 manufacturer,IHMT-PI3Kδ-372 distributor,IHMT-PI3Kδ-372 cost,IHMT-PI3Kδ-372 buy,IHMT-PI3Kδ-372 for sale